Published Study Demonstrates Natera's Ability to Identify Heterogeneous Cancer Mutations in Patients with Early-Stage Lung Cancer
Go back to Published Study Demonstrates Natera's Ability to Identify Heterogeneous Cancer Mutations in Patients with Early-Stage Lung Cancer| (NASDAQ: NTRA) | Delayed: 403.95 +2.58 (0.64%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $401.37 | 52 Week High | $13.80 | |||
| Open | $399.95 | 52 Week Low | $6.52 | |||
| Day High | $408.28 | P/E | N/A | |||
| Day Low | $395.33 | EPS | $0.00 | |||
| Volume | 1,101,923 | |||||



